OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 19
Showing 19 citing articles:
Development of a Recombinant Omicron BA .1 Subunit Vaccine Candidate in Pichia pastoris
Sibel Kalyoncu, Dogu Sayili, Ayça Zeybek Kuyucu, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Sibel Kalyoncu, Dogu Sayili, Ayça Zeybek Kuyucu, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Vaccines reimagined: The peptide revolution in disease prevention
Vivek P. Chavda
Progress in molecular biology and translational science (2025), pp. 329-354
Closed Access
Vivek P. Chavda
Progress in molecular biology and translational science (2025), pp. 329-354
Closed Access
Oral delivery of protein and peptide therapeutics
Vivek P. Chavda, Pankti C. Balar
Progress in molecular biology and translational science (2025), pp. 355-387
Closed Access
Vivek P. Chavda, Pankti C. Balar
Progress in molecular biology and translational science (2025), pp. 355-387
Closed Access
Polyvalent immunoprotection of protein, DNA and IgY antibody vaccines of Vibrio fluvialis outer membrane protein VF08100 in fish
Huihui Xiao, Song Duan, Pan Cui, et al.
Fish & Shellfish Immunology (2025), pp. 110260-110260
Closed Access
Huihui Xiao, Song Duan, Pan Cui, et al.
Fish & Shellfish Immunology (2025), pp. 110260-110260
Closed Access
AI in the development of vaccines for emerging and re-emerging diseases
Rita Elizabeth Velastegui-Hernández, Verónica Gabriela Salinas Velasteguí, Diana Catalina Velasteguí Hernández, et al.
Salud Ciencia y Tecnología (2025) Vol. 4
Closed Access
Rita Elizabeth Velastegui-Hernández, Verónica Gabriela Salinas Velasteguí, Diana Catalina Velasteguí Hernández, et al.
Salud Ciencia y Tecnología (2025) Vol. 4
Closed Access
Shortcomings of Current Adjuvants and Future Prospects
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda
(2025), pp. 255-261
Closed Access
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda
(2025), pp. 255-261
Closed Access
A Self-Assembled Nanovaccine with BA.4/5 Receptor-Binding Domain and CpG Oligodeoxynucleotides Induces Broad-Spectrum Neutralization against SARS-CoV-2 Omicron Subvariants
Chendong Yang, Entao Li, Xiaoping Guo, et al.
ACS Nano (2025)
Closed Access
Chendong Yang, Entao Li, Xiaoping Guo, et al.
ACS Nano (2025)
Closed Access
Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Non-Glycosylated SARS-CoV-2 Omicron BA.5 Receptor Binding Domain (RBD) with a Native-like Conformation Induces a Robust Immune Response with Potent Neutralization in a Mouse Model
Rawiwan Wongnak, Subbaian Brindha, Mami Oba, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2676-2676
Open Access | Times Cited: 1
Rawiwan Wongnak, Subbaian Brindha, Mami Oba, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2676-2676
Open Access | Times Cited: 1
Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection
Kaiwen Yang, Youqin Zeng, Xinyu Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Kaiwen Yang, Youqin Zeng, Xinyu Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
A “plug-and-display” nanoparticle based on attenuated outer membrane vesicles enhances the immunogenicity of protein antigens
Xiaohui Bai, Chenyang Li, Jiahui Qiu, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 687-700
Closed Access | Times Cited: 1
Xiaohui Bai, Chenyang Li, Jiahui Qiu, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 687-700
Closed Access | Times Cited: 1
Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-CoV-2 and its variants
Berenice Calderón-Pérez, Leandro Alberto Núñez-Muñoz, Lady Laura Trejo-Ayala, et al.
Virology (2024) Vol. 603, pp. 110380-110380
Closed Access | Times Cited: 1
Berenice Calderón-Pérez, Leandro Alberto Núñez-Muñoz, Lady Laura Trejo-Ayala, et al.
Virology (2024) Vol. 603, pp. 110380-110380
Closed Access | Times Cited: 1
How do we change our approach to COVID with the changing face of disease?
Vasso Apostolopoulos, Jack Feehan, Vivek P. Chavda
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 5, pp. 279-287
Closed Access
Vasso Apostolopoulos, Jack Feehan, Vivek P. Chavda
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 5, pp. 279-287
Closed Access
Coronavirus spike protein-based vaccines. Vaccine delivery systems
Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu, et al.
Medicine in Drug Discovery (2024), pp. 100198-100198
Open Access
Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu, et al.
Medicine in Drug Discovery (2024), pp. 100198-100198
Open Access
Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
Nelli S. Khudainazarova, Dmitriy L. Granovskiy, О. А. Кондакова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11979-11979
Open Access
Nelli S. Khudainazarova, Dmitriy L. Granovskiy, О. А. Кондакова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11979-11979
Open Access
Synthesis, characterization, proteolytic activity inhibition, ADMET prediction, and molecular docking studies of novel indole derivatives as potential SARS-CoV-2 protease inhibitors
Abdelali Chihab, Nabil El Brahmi, Abdelmoula El Abbouchi, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140707-140707
Closed Access
Abdelali Chihab, Nabil El Brahmi, Abdelmoula El Abbouchi, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140707-140707
Closed Access
Single dose of recombinant baculovirus vaccine expressing sigma B and sigma C genes provides good protection against novel duck reovirus challenge in ducks
Yufei Wang, Siyi Xu, Xia Chen, et al.
Poultry Science (2024) Vol. 104, Iss. 1, pp. 104565-104565
Open Access
Yufei Wang, Siyi Xu, Xia Chen, et al.
Poultry Science (2024) Vol. 104, Iss. 1, pp. 104565-104565
Open Access
A Subunit Vaccine Harboring the Fusion Capsid Proteins of Porcine Circovirus Types 2, 3, and 4 Induces Protective Immune Responses in a Mouse Model
Qikai Wang, Ran Zhang, Yue Wang, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1964-1964
Open Access
Qikai Wang, Ran Zhang, Yue Wang, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1964-1964
Open Access
